ZA200702971B - Method for treatment with bucindolol based on genetic targeting - Google Patents
Method for treatment with bucindolol based on genetic targetingInfo
- Publication number
- ZA200702971B ZA200702971B ZA200702971A ZA200702971A ZA200702971B ZA 200702971 B ZA200702971 B ZA 200702971B ZA 200702971 A ZA200702971 A ZA 200702971A ZA 200702971 A ZA200702971 A ZA 200702971A ZA 200702971 B ZA200702971 B ZA 200702971B
- Authority
- ZA
- South Africa
- Prior art keywords
- treatment
- genetic targeting
- bucindolol
- bucindolol based
- targeting
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60968904P | 2004-09-14 | 2004-09-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200702971B true ZA200702971B (en) | 2009-09-30 |
Family
ID=38938240
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200702971A ZA200702971B (en) | 2004-09-14 | 2007-04-11 | Method for treatment with bucindolol based on genetic targeting |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101087891A (en) |
ZA (1) | ZA200702971B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106370754B (en) * | 2016-11-07 | 2019-03-08 | 西安科技大学 | Based on chiral high performance liquid chromatography-mass spectrum/mass-spectrometric technique quantitative detection bucindolol optical isomer content method |
-
2005
- 2005-09-14 CN CN 200580038580 patent/CN101087891A/en active Pending
-
2007
- 2007-04-11 ZA ZA200702971A patent/ZA200702971B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101087891A (en) | 2007-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0526291D0 (en) | Therapeutic method | |
EP1756738A4 (en) | Content-management system for user behavior targeting | |
GB0402131D0 (en) | Delivery method | |
EP1803244A4 (en) | Enciphering method | |
EP1715799A4 (en) | Glaucoma treatment method | |
IL186542A0 (en) | Improved methods controlling gene expression | |
EP1807966A4 (en) | Authentication method | |
HK1083376A1 (en) | Dual-path-pre-approval authentication method | |
MX305616B (en) | Methods for increasing maize yields. | |
IL183889A0 (en) | Treatment method | |
EP1819639A4 (en) | Nebulizing treatment method | |
WO2007056113A9 (en) | Methods for targeting quadruplex sequences | |
EP1755394A4 (en) | Cancer treatment method | |
HK1117871A1 (en) | Methods for delivering genes | |
EP1765344A4 (en) | Cancer treatment method | |
EP1809276A4 (en) | Treatment method | |
EP1846432A4 (en) | Method for making targeted therapeutic agents | |
ZA200707236B (en) | Microorganisms for therapy | |
GB0406728D0 (en) | Gene therapy | |
ZA200702971B (en) | Method for treatment with bucindolol based on genetic targeting | |
GB0607153D0 (en) | Therapeutic Method | |
IL164850A0 (en) | Gene therapy for kidney diseases | |
GB0606660D0 (en) | Targeted Therapy | |
GB0420822D0 (en) | Therapeutic method | |
GB0420823D0 (en) | Therapeutic method |